Easing acceleration of head and neck chemoradiotherapy

Missak Haigentz, June Corry, Primoz Strojan, Alfio Ferlito

Research output: Contribution to journalArticle

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)113-115
Number of pages3
JournalThe Lancet Oncology
Volume13
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Chemoradiotherapy
Head and Neck Neoplasms
Neck
Head
Carcinoma

ASJC Scopus subject areas

  • Oncology

Cite this

Haigentz, M., Corry, J., Strojan, P., & Ferlito, A. (2012). Easing acceleration of head and neck chemoradiotherapy. The Lancet Oncology, 13(2), 113-115. https://doi.org/10.1016/S1470-2045(11)70382-5

Easing acceleration of head and neck chemoradiotherapy. / Haigentz, Missak; Corry, June; Strojan, Primoz; Ferlito, Alfio.

In: The Lancet Oncology, Vol. 13, No. 2, 02.2012, p. 113-115.

Research output: Contribution to journalArticle

Haigentz, M, Corry, J, Strojan, P & Ferlito, A 2012, 'Easing acceleration of head and neck chemoradiotherapy', The Lancet Oncology, vol. 13, no. 2, pp. 113-115. https://doi.org/10.1016/S1470-2045(11)70382-5
Haigentz, Missak ; Corry, June ; Strojan, Primoz ; Ferlito, Alfio. / Easing acceleration of head and neck chemoradiotherapy. In: The Lancet Oncology. 2012 ; Vol. 13, No. 2. pp. 113-115.
@article{f323d87cebc047fcadca5f6f1e2cffc1,
title = "Easing acceleration of head and neck chemoradiotherapy",
author = "Missak Haigentz and June Corry and Primoz Strojan and Alfio Ferlito",
year = "2012",
month = "2",
doi = "10.1016/S1470-2045(11)70382-5",
language = "English (US)",
volume = "13",
pages = "113--115",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "2",

}

TY - JOUR

T1 - Easing acceleration of head and neck chemoradiotherapy

AU - Haigentz, Missak

AU - Corry, June

AU - Strojan, Primoz

AU - Ferlito, Alfio

PY - 2012/2

Y1 - 2012/2

UR - http://www.scopus.com/inward/record.url?scp=84856411489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856411489&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(11)70382-5

DO - 10.1016/S1470-2045(11)70382-5

M3 - Article

VL - 13

SP - 113

EP - 115

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 2

ER -